Enhancing the Impact of Digital Therapeutics in Cancer Prevention: Reflections on Recent Findings
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s13187-024-02474-1.pdf
Reference7 articles.
1. Zhang X, Zhang S, Zhang H et al (2024) Feasibility and acceptability evaluation of a digital therapeutic program for improving cancer prevention: a quasi-experimental pre-post interventional pilot study. J Canc Educ. https://doi.org/10.1007/s13187-024-02431-y
2. Colditz GA, Wei EK (2012) Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. Annu Rev Public Health 33:137–156. https://doi.org/10.1146/annurev-publhealth-031811-124627
3. Ware JE, Sherbourne CD (1992) The MOS 36-Item Short-Form Health Survey (SF-36): I. conceptual framework and item selection. Med Care 30(6):473–483
4. Dahl AK, Hassing LB, Fransson EI et al (2010) Agreement between self-reported and measured height, weight and body mass index in old age–a longitudinal study with 20 years of follow-up. Age Ageing 39(4):445–451
5. Basch E, Mody GN, Dueck AC (2020) Electronic patient-reported outcomes as digital therapeutics to improve cancer outcomes. JCO Oncol Pract 16(9):541–542
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3